Related Experiment Video
Updated: Aug 5, 2026

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
Published on: June 24, 2012
Replication-defective mutants of mouse cytomegalovirus protect against wild-type virus challenge
T A Gill1, P J Morley, C Sweet
1Microbial Molecular Genetics and Cell Biology research Group, School of Biosciences, The University of Birmingham, Birmingham, B15 2TT.
Abstract:
Five temperature-sensitive mutants (tsm9, tsm13, tsm20, tsm22, tsm30) of murine cytomegalovirus have been shown previously not to produce infectious virus in mice. In the present study, the stage at which these mutants are blocked in their replication in vitro was examined by transcriptional analysis of 4 temporally regulated marker genes (IE-1, E-1, gB and gH) using a semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) coupled with an electron microscopic analysis of infected cells incubated at permissive (33 degrees C) and non-permissive (39 and/or 40 degrees C) temperatures. Replication of tsm13 appeared to be blocked at a late phase of replication after capsid formation while the block appeared to be as early as the immediate-early phase in tsm22- infected cells. In contrast, mutants tsm9, tsm20 and tsm30 were blocked at a maturation step, probably of capsid formation, as gene transcription of all 4 marker genes occurred, albeit at reduced level, at 39 and 40 degrees C but no capsids or virions were produced at 40 degrees C. Replication and transcription of mutants tsm13, tsm20 and tsm30 were also examined in infected mice. Mutant tsm13 showed no gene expression or infectious virus while mutants tsm20 and tsm30 produced no infectious virus from days 3-60 post infection, except unusually for a low titre of tsm30 (2.3 x 10(3) pfu/ml) in salivary glands 21 days post infection. Gene transcription of all 4 marker genes was observed in one or more tissues (salivary glands, spleen, kidneys, liver, thymus, heart, lungs) at one or more time points (3, 7, 10, 14, 21 days post-infection) with both mutants. Mice became infected latently with tsm20 but not tsm30, and mice previously infected with tsm20 or tsm30 were protected against a sub-lethal challenge with virulent parental virus; tsm30 also protected against a lethal challenge. This suggests that these two mutants may be good model vaccines for further studies on the mechanism of protection induced and for identification of the ts genes.
Insights
Five temperature-sensitive murine cytomegalovirus mutants were analyzed for replication blocks. Mutants tsm20 and tsm30 showed potential as vaccine models due to induced protection against virulent virus challenges.
Area of Science:
- Virology
- Immunology
- Genetics
Background:
- Murine cytomegalovirus (MCMV) temperature-sensitive mutants (tsm) are valuable tools for studying viral replication.
- Previous studies identified five MCMV tsm mutants (tsm9, tsm13, tsm20, tsm22, tsm30) that do not produce infectious virus in mice.
Purpose of the Study:
- To determine the replication block stage of five MCMV temperature-sensitive mutants in vitro.
- To investigate the in vivo replication and immunogenic potential of selected MCMV tsm mutants.
Main Methods:
- Transcriptional analysis of four temporally regulated genes (IE-1, E-1, gB, gH) using semi-quantitative reverse transcription polymerase chain reaction (RT-PCR).
- Electron microscopic analysis of infected cells at permissive (33°C) and non-permissive (39-40°C) temperatures.
- In vivo replication and transcription studies in infected mice, followed by challenge experiments.
Main Results:
- Replication blocks varied from immediate-early (tsm22) to late phases (tsm13) and maturation/capsid formation (tsm9, tsm20, tsm30).
- Mutants tsm20 and tsm30 exhibited no infectious virus production in mice but showed gene transcription in various tissues.
- Mice infected with tsm20 or tsm30 were protected against virulent MCMV challenge, with tsm30 also providing protection against lethal challenge.
Conclusions:
- The study elucidates the distinct replication defects of MCMV temperature-sensitive mutants.
- Mutants tsm20 and tsm30 demonstrate potential as live vaccine candidates for inducing protective immunity against MCMV infection.
Related Concept Videos
In-vitro Mutagenesis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cytomegalovirus Disease

